Coagulopathy, catecholamines, and biomarkers of endothelial damage in experimental human endotoxemia and in patients with severe sepsis: a prospective study

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Coagulopathy, catecholamines, and biomarkers of endothelial damage in experimental human endotoxemia and in patients with severe sepsis : a prospective study. / Ostrowski, Sisse R; Berg, Ronan M G; Windeløv, Nis A; Meyer, Martin A S; Plovsing, Ronni R; Møller, Kirsten; Johansson, Pär I.

In: Journal of Critical Care, Vol. 28, No. 5, 10.2013, p. 586-96.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Ostrowski, SR, Berg, RMG, Windeløv, NA, Meyer, MAS, Plovsing, RR, Møller, K & Johansson, PI 2013, 'Coagulopathy, catecholamines, and biomarkers of endothelial damage in experimental human endotoxemia and in patients with severe sepsis: a prospective study', Journal of Critical Care, vol. 28, no. 5, pp. 586-96. https://doi.org/10.1016/j.jcrc.2013.04.010

APA

Ostrowski, S. R., Berg, R. M. G., Windeløv, N. A., Meyer, M. A. S., Plovsing, R. R., Møller, K., & Johansson, P. I. (2013). Coagulopathy, catecholamines, and biomarkers of endothelial damage in experimental human endotoxemia and in patients with severe sepsis: a prospective study. Journal of Critical Care, 28(5), 586-96. https://doi.org/10.1016/j.jcrc.2013.04.010

Vancouver

Ostrowski SR, Berg RMG, Windeløv NA, Meyer MAS, Plovsing RR, Møller K et al. Coagulopathy, catecholamines, and biomarkers of endothelial damage in experimental human endotoxemia and in patients with severe sepsis: a prospective study. Journal of Critical Care. 2013 Oct;28(5):586-96. https://doi.org/10.1016/j.jcrc.2013.04.010

Author

Ostrowski, Sisse R ; Berg, Ronan M G ; Windeløv, Nis A ; Meyer, Martin A S ; Plovsing, Ronni R ; Møller, Kirsten ; Johansson, Pär I. / Coagulopathy, catecholamines, and biomarkers of endothelial damage in experimental human endotoxemia and in patients with severe sepsis : a prospective study. In: Journal of Critical Care. 2013 ; Vol. 28, No. 5. pp. 586-96.

Bibtex

@article{d793e48223fa4ad0a7b940890b8dee24,
title = "Coagulopathy, catecholamines, and biomarkers of endothelial damage in experimental human endotoxemia and in patients with severe sepsis: a prospective study",
abstract = "PURPOSE: The aim of this study was to investigate associations between circulating catecholamines, endothelial damage, and coagulopathy in experimental human endotoxemia and septic patients.MATERIALS AND METHODS: Nine healthy male volunteers undergoing endotoxemia (4-hour 0.5 ng/kg/hour infusion of E. coli lipopolysaccharide, blood sampling at 0, 4, and 6 hours) and 20 patients with severe sepsis. Analysis of plasma biomarkers (adrenaline, noradrenaline, thrombomodulin, syndecan-1, soluble vascular endothelial cadherin, histone-complexed DNA fragments, soluble CD40 ligand [sCD40L], protein C, tissue-type plasminogen activator, plasminogen activator inhibitor 1) and routine coagulation tests.RESULTS: Endotoxemia increased heart rate, temperature, white blood cell count, C-reactive protein and procalcitonin, decreased blood pressure and induced a hemostatic response with platelet consumption, reduced protein C and sCD40L levels and enhanced tissue-type plasminogen activator release (all P<.05). Septic patients had increased levels of noradrenaline, syndecan-1, thrombomodulin, histone-complexed DNA and sCD40L but reduced soluble vascular endothelial cadherin and plasminogen activator inhibitor 1 (all P<.05) and plasma catecholamines correlated positively with syndecan-1 (adrenaline and noradrenaline) and sTM (only noradrenaline) (all P<.05), biomarkers reflecting endothelial damage. Furthermore, noradrenaline, syndecan-1 and thrombomodulin levels correlated with INR and disease severity scores (noradrenaline and thrombomodulin) (all P<.05).CONCLUSIONS: Experimental endotoxemia induced a discrete hemostatic response without sympathoadrenal activation or endothelial damage. Septic patients had high levels of catecholamines and endothelial damage biomarkers that correlated with each other and with markers of hypocoagulability and disease severity.",
keywords = "Adult, Biomarkers/blood, Blood Coagulation Disorders/blood, Catecholamines/blood, Endotoxemia/blood, Healthy Volunteers, Humans, Male, Prospective Studies, Sepsis/blood, Severity of Illness Index",
author = "Ostrowski, {Sisse R} and Berg, {Ronan M G} and Windel{\o}v, {Nis A} and Meyer, {Martin A S} and Plovsing, {Ronni R} and Kirsten M{\o}ller and Johansson, {P{\"a}r I}",
note = "Copyright {\textcopyright} 2013 Elsevier Inc. All rights reserved.",
year = "2013",
month = oct,
doi = "10.1016/j.jcrc.2013.04.010",
language = "English",
volume = "28",
pages = "586--96",
journal = "Journal of Critical Care",
issn = "0883-9441",
publisher = "W.B.Saunders Co.",
number = "5",

}

RIS

TY - JOUR

T1 - Coagulopathy, catecholamines, and biomarkers of endothelial damage in experimental human endotoxemia and in patients with severe sepsis

T2 - a prospective study

AU - Ostrowski, Sisse R

AU - Berg, Ronan M G

AU - Windeløv, Nis A

AU - Meyer, Martin A S

AU - Plovsing, Ronni R

AU - Møller, Kirsten

AU - Johansson, Pär I

N1 - Copyright © 2013 Elsevier Inc. All rights reserved.

PY - 2013/10

Y1 - 2013/10

N2 - PURPOSE: The aim of this study was to investigate associations between circulating catecholamines, endothelial damage, and coagulopathy in experimental human endotoxemia and septic patients.MATERIALS AND METHODS: Nine healthy male volunteers undergoing endotoxemia (4-hour 0.5 ng/kg/hour infusion of E. coli lipopolysaccharide, blood sampling at 0, 4, and 6 hours) and 20 patients with severe sepsis. Analysis of plasma biomarkers (adrenaline, noradrenaline, thrombomodulin, syndecan-1, soluble vascular endothelial cadherin, histone-complexed DNA fragments, soluble CD40 ligand [sCD40L], protein C, tissue-type plasminogen activator, plasminogen activator inhibitor 1) and routine coagulation tests.RESULTS: Endotoxemia increased heart rate, temperature, white blood cell count, C-reactive protein and procalcitonin, decreased blood pressure and induced a hemostatic response with platelet consumption, reduced protein C and sCD40L levels and enhanced tissue-type plasminogen activator release (all P<.05). Septic patients had increased levels of noradrenaline, syndecan-1, thrombomodulin, histone-complexed DNA and sCD40L but reduced soluble vascular endothelial cadherin and plasminogen activator inhibitor 1 (all P<.05) and plasma catecholamines correlated positively with syndecan-1 (adrenaline and noradrenaline) and sTM (only noradrenaline) (all P<.05), biomarkers reflecting endothelial damage. Furthermore, noradrenaline, syndecan-1 and thrombomodulin levels correlated with INR and disease severity scores (noradrenaline and thrombomodulin) (all P<.05).CONCLUSIONS: Experimental endotoxemia induced a discrete hemostatic response without sympathoadrenal activation or endothelial damage. Septic patients had high levels of catecholamines and endothelial damage biomarkers that correlated with each other and with markers of hypocoagulability and disease severity.

AB - PURPOSE: The aim of this study was to investigate associations between circulating catecholamines, endothelial damage, and coagulopathy in experimental human endotoxemia and septic patients.MATERIALS AND METHODS: Nine healthy male volunteers undergoing endotoxemia (4-hour 0.5 ng/kg/hour infusion of E. coli lipopolysaccharide, blood sampling at 0, 4, and 6 hours) and 20 patients with severe sepsis. Analysis of plasma biomarkers (adrenaline, noradrenaline, thrombomodulin, syndecan-1, soluble vascular endothelial cadherin, histone-complexed DNA fragments, soluble CD40 ligand [sCD40L], protein C, tissue-type plasminogen activator, plasminogen activator inhibitor 1) and routine coagulation tests.RESULTS: Endotoxemia increased heart rate, temperature, white blood cell count, C-reactive protein and procalcitonin, decreased blood pressure and induced a hemostatic response with platelet consumption, reduced protein C and sCD40L levels and enhanced tissue-type plasminogen activator release (all P<.05). Septic patients had increased levels of noradrenaline, syndecan-1, thrombomodulin, histone-complexed DNA and sCD40L but reduced soluble vascular endothelial cadherin and plasminogen activator inhibitor 1 (all P<.05) and plasma catecholamines correlated positively with syndecan-1 (adrenaline and noradrenaline) and sTM (only noradrenaline) (all P<.05), biomarkers reflecting endothelial damage. Furthermore, noradrenaline, syndecan-1 and thrombomodulin levels correlated with INR and disease severity scores (noradrenaline and thrombomodulin) (all P<.05).CONCLUSIONS: Experimental endotoxemia induced a discrete hemostatic response without sympathoadrenal activation or endothelial damage. Septic patients had high levels of catecholamines and endothelial damage biomarkers that correlated with each other and with markers of hypocoagulability and disease severity.

KW - Adult

KW - Biomarkers/blood

KW - Blood Coagulation Disorders/blood

KW - Catecholamines/blood

KW - Endotoxemia/blood

KW - Healthy Volunteers

KW - Humans

KW - Male

KW - Prospective Studies

KW - Sepsis/blood

KW - Severity of Illness Index

U2 - 10.1016/j.jcrc.2013.04.010

DO - 10.1016/j.jcrc.2013.04.010

M3 - Journal article

C2 - 23731819

VL - 28

SP - 586

EP - 596

JO - Journal of Critical Care

JF - Journal of Critical Care

SN - 0883-9441

IS - 5

ER -

ID: 236993380